Panel Q & A Session on ALK+ and ROS1 Acquired Resistance with Drs. Horn and Owonikoko [360p]
Janet Daily-Freeman moderates a question & answer session with Drs. Leora Horn and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for ALK+ and ROS1 patients.
Author: cancergrace
Added: 03/23/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology